Evidence map›Paper›PMID 37644016›Full record

ArticleNature communications2023

Cobalt-catalyzed atroposelective C-H activation/annulation to access N-N axially chiral frameworks.

Tong Li, Linlin Shi, Xinhai Wang, Chen Yang, Dandan Yang, Mao-Ping Song, Jun-Long Niu

Abstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Cobalt-Catalyzed Asymmetric Construction of Boron Stereocenters With C-N Axial Chirality.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Chemical science · 2026
    Article
  4. Installing Axial Chirality by Atroposelective C(spJournal of the American Chemical Society · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Parametrization of κACS catalysis · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Atroposelective catalysis.Nature reviews. Chemistry · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tong Li *College of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Linlin Shi *College of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Xinhai WangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Chen YangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Dandan YangCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China. yangdandan@zzu.edu.cn.ORCID http://orcid.org/0000-0002-1880-8417
Mao-Ping SongCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China.
Jun-Long NiuCollege of Chemistry, Zhengzhou University, Zhengzhou, 450001, P. R. China. niujunlong@zzu.edu.cn.ORCID http://orcid.org/0000-0001-8012-4676

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21772179National Natural Science Foundation of China (National Science Foundation of China) 22101267
6 · The paper itself

Abstract

The N-N atropisomer, as an important and intriguing chiral system, was widely present in natural products, pharmaceutical lead compounds, and advanced material skeletons. The anisotropic structural characteristics caused by its special axial rotation have always been one of the challenges that chemists strive to overcome. Herein, we report an efficient method for the enantioselective synthesis of N-N axially chiral frameworks via a cobalt-catalyzed atroposelective C-H activation/annulation process. The reaction proceeds under mild conditions by using Co(OAc)

Identifiers

PMID37644016
PMCPMC10465517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.